The 15th edition of BIO-Europe Spring, Europe’s largest life sciences partnering event which was scheduled to take place in Barcelona for the fourth time, will be completely virtual due to the COVID-19 pandemic from 22 to 25 March, 2021.

Biocat, CataloniaBio & HealthTech and ACCIÓ (Government of Catalonia) have signed a collaboration agreement as Platinum Sponsors with the aim of promoting the Catalan ecosystem's delegation at the event.

BIO-Europe Spring includes access to company pitches, programme sessions, and sponsor and company showcase content up to five weeks before the event for the best possible networking and meeting decisions once partnering begins. 

This year’s event expects to bring together more than 2,500 executives from over 1,300 companies and host more than 15,000 meetings. 

Programme

Check out the programmme of speeches, conferences and presentations of BIO-Europe Spring 2021. 

We would like to highlight the Investment success stories that make Catalonia the healthcare innovation hotspot of Europe panel discussion, which will take a closer look at the strength of investment in Catalonia through case studies of some of the most successful companies headquartered there. Get to know the CEOs of three companies who have experienced first-hand why Catalonia is one of Europe's innovation hotspots.

Moderator: Judit Anido, CEO of CataloniaBio & HealthTech

Speakers:

• Valerie Vanhooren, co-founder and CEO of Ona Therapeutics
• Ana Maiques, co-founder and CEO of Neuroelectrics
• Stephen Dunne, Chief Digital Therapeutics Officer of Koa Health

As part of this debate, Jordi Naval, CEO of Biocat, will present the main investment indicators for the health and life sciences sector in Catalonia in 2020.

Closing remarks by Joan Martí, director of Clusters Unit at Catalonia Trade & Investment (Government of Catalonia).

Catalan companies at BIO-Europe Spring 2021

The following Catalan companies, investors and entities are expected to attend:

• Ability Pharmaceuticals
• Almirall
• Alta Life Sciences
• Anapharm Europe
• Asphalion
• Aromics
• BCN Peptides
• Bioingenium
• BioPharma Synergies 
• Biosfer Teslab
• Drug Development & Regulation (DDR)
• Enantia
• Ferrer
• Fundació Bosch i Gimpera
• Gate2Brain
• Gebro Pharma
• GP Pharm
• Institute for Bioengineering of Catalonia (IBEC)
• Josep Carreras Leukaemia Research Institute
• Pere Virgili Institute (IISPV)
• Intas Pharmaceuticals
• Kintsugi Therapeutics
• Laboratorios Rubió
• LGAI Technological Center
• Leitat
• Leukos Biotech
• OneChain Immunotherapeutics
• Peptomyc
• Polypeptide Therapeutic Solutions
• Salvat
• SOM Biotech
• The Patients Resource
• Therapeutic Solutions
• 3DforScience Visuals for Bio & Health
• Trifermed
• Universitat Pompeu Fabra
• Uquifa
• Vall d'Hebron Institut de Recerca (VHIR)
• Zymvol Biomodeling

Participation advantages for Catalan companies

Pre-revenue biotech companies founded before 2018, Technology Transfer Offices and Academia

5 registrations for the price of 1 ticket: 

• €1,495 - 20% discount = €1,196 € (VAT not included)

Discount code: BIOCAT2021

Post-revenue companies and investors

Price per registration:

• €1,495 € - 20% discount = €1,196 (VAT not included)

Discount code: BIOCAT2021

Pre-revenue biotech companies that:

• Were founded between 2018 and 2021 (within the past 3 years)
• Are developing their own pipeline of therapies or diagnostics
• Have no more than 10 employees
• Register 5 delegates for the conference (from the same company)

5 registrations for €495 (VAT not included)

Discount code: BIOCAT2021

Presentations 

If you are interested in presenting your company or project, sign up here. 

• Next Generation Presentation: €560 (VAT not included)
• Academic Innovator Presentation: €455 (VAT not included)
• Biotech / Midsize Pharma: €945 (VAT not included)

Do you have news to share with the sector?

Contact us and we will include it in our BIO-Europe Spring dissemination materials (websites, press releases, social media, etc.).

CataloniaBio & HealthTech members: Gemma Escarré (Head of Communications) · comunicacio@cataloniabioht.org

Non-members: Biocat · Silvia Labé (Director of Communication and Marketing) · slabe@biocat.cat

For: senior executives of leading biotech companies, business development teams from pharmaceutical companies and investors.

Questions: Melqui Calzado (General secretary) · melqui.calzado@cataloniabioht.org

Follow us on Twitter with the hashtag #BIOEuropeSpring.